Table 3 Number of first and second treated eyes, median, and categories of visual acuity at the start of treatment.
From: Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
First eyes | Second eyes | |
|---|---|---|
Eyes (n) | 9182 | 3232 |
Median baseline LogMAR (IQR) | 0.50 (0.30, 0.88) | 0.38 (0.20, 0.64) |
LogMAR ≤ 0.3 (%) | 31.2 | 44.2 |
LogMAR 0.32 to 0.58 (%) | 24.6 | 26.1 |
LogMAR 0.60 to 0.98 (%) | 24.3 | 19.2 |
LogMAR ≥ 1.0 (%) | 19.9 | 10.6 |
